Organicell Regenerative Medicine, Inc. – OTC:OCEL
Organicell Regenerative Medicine stock price today
Organicell Regenerative Medicine stock price monthly change
Organicell Regenerative Medicine stock price quarterly change
Organicell Regenerative Medicine stock price yearly change
Organicell Regenerative Medicine key metrics
Market Cap | 25.09M |
Enterprise value | 13.72M |
P/E | -1.05 |
EV/Sales | 2.30 |
EV/EBITDA | -1.59 |
Price/Sales | 2.46 |
Price/Book | 21.74 |
PEG ratio | -0.04 |
EPS | -1 |
Revenue | 4.55M |
EBITDA | -6.06M |
Income | -7.17M |
Revenue Q/Q | -1.49% |
Revenue Y/Y | -29.77% |
Profit margin | -159.16% |
Oper. margin | -157.29% |
Gross margin | 88.11% |
EBIT margin | -157.29% |
EBITDA margin | -133.14% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOrganicell Regenerative Medicine stock price history
Organicell Regenerative Medicine stock forecast
Organicell Regenerative Medicine financial statements
| Jan 2023 | 1.07M | -2.39M | -223.97% |
|---|---|---|---|
| Apr 2023 | 845.50K | -2.06M | -244.81% |
| Jul 2023 | 1.22M | -1.61M | -132.53% |
| Oct 2023 | 1.42M | -1.09M | -76.73% |
| Jan 2023 | 4317796 | 3.64M | 84.32% |
|---|---|---|---|
| Apr 2023 | 3334584 | 3.47M | 104.17% |
| Jul 2023 | 2455661 | 3.47M | 141.59% |
| Oct 2023 | 2782200 | 4.02M | 144.61% |
| Jan 2023 | -1.28M | -16.11K | -1.03M |
|---|---|---|---|
| Apr 2023 | -670.85K | -99.99K | 479.28K |
| Jul 2023 | -464.15K | -3.53K | -29.66K |
| Oct 2023 | 220.45K | 735.22K | 166.94K |
Organicell Regenerative Medicine alternative data
| Aug 2023 | 20 |
|---|---|
| Sep 2023 | 20 |
| Oct 2023 | 20 |
| Nov 2023 | 20 |
| Dec 2023 | 20 |
| Jan 2024 | 20 |
| Feb 2024 | 20 |
| Mar 2024 | 20 |
| Apr 2024 | 20 |
| May 2024 | 20 |
| Jun 2024 | 20 |
| Jul 2024 | 20 |
Organicell Regenerative Medicine other data
| Period | Buy | Sel |
|---|---|---|
| Jun 2023 | 2449450 | 0 |
| Jul 2023 | 320710 | 0 |
| Dec 2023 | 0 | 5248 |
-
What's the price of Organicell Regenerative Medicine stock today?
One share of Organicell Regenerative Medicine stock can currently be purchased for approximately $0.01.
-
When is Organicell Regenerative Medicine's next earnings date?
Unfortunately, Organicell Regenerative Medicine's (OCEL) next earnings date is currently unknown.
-
Does Organicell Regenerative Medicine pay dividends?
No, Organicell Regenerative Medicine does not pay dividends.
-
How much money does Organicell Regenerative Medicine make?
Organicell Regenerative Medicine has a market capitalization of 25.09M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 29.78% to 4.56M US dollars.
-
What is Organicell Regenerative Medicine's stock symbol?
Organicell Regenerative Medicine, Inc. is traded on the OTC under the ticker symbol "OCEL".
-
What is Organicell Regenerative Medicine's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Organicell Regenerative Medicine?
Shares of Organicell Regenerative Medicine can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Organicell Regenerative Medicine have?
As Jul 2024, Organicell Regenerative Medicine employs 20 workers.
-
When Organicell Regenerative Medicine went public?
Organicell Regenerative Medicine, Inc. is publicly traded company for more then 9 years since IPO on 1 Mar 2016.
-
What is Organicell Regenerative Medicine's official website?
The official website for Organicell Regenerative Medicine is organicell.com.
-
Where are Organicell Regenerative Medicine's headquarters?
Organicell Regenerative Medicine is headquartered at 4045 Sheridan Avenue, Miami, FL.
-
How can i contact Organicell Regenerative Medicine?
Organicell Regenerative Medicine's mailing address is 4045 Sheridan Avenue, Miami, FL and company can be reached via phone at +888 9637881.
Organicell Regenerative Medicine company profile:
Organicell Regenerative Medicine, Inc.
organicell.comOTC
20
Biotechnology
Healthcare
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19, COPD, and osteoarthritis. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.
Miami, FL 33136
CIK: 0001557376
ISIN: US68621D1072
CUSIP: 68621D107
